Home / Share Price Target / Mankind
Mankind Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Mankind Pharma Limited | |||
 | Symbol: MANKIND | ||
| Price: ₹2,597.64 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Mankind Pharma Brief Company Overview
- 1.1: Company Overview: Mankind Pharma Limited
- 1.2: Mankind Pharma Financial Performance
- 1.2.1: Is Mankind Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Mankind Pharma Share Price Target For 2024
- 2.1.1: Mankind Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Mankind Pharma Share Price Prediction For 2024
- 2.2: Mankind Pharma Share Price Target For 2025
- 2.2.1: Mankind Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Mankind Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Mankind Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Mankind Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Mankind Pharma Past Performance
Mankind Pharma Brief Company Overview
Company Overview: Mankind Pharma Limited
Mankind Pharma Limited, founded in 1986, is a leading pharmaceutical company in India with a global presence. They specialize in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.
Mankind Pharma's product portfolio encompasses acute and chronic therapeutics, including anti-infectives, cardiovascular medications, gastrointestinal treatments, anti-diabetics, dermatological solutions, pain/analgesics, neuro/CNS drugs, vitamins/minerals/nutrients, and respiratory medications.
In addition to pharmaceuticals, they offer a wide range of consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations.
The company's commitment to innovation and quality has earned it a strong reputation in the industry. Mankind Pharma's products are marketed under well-established brand names, including Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar.
With a focus on customer satisfaction, Mankind Pharma is committed to providing affordable and effective healthcare solutions to meet the needs of its customers.
Advertisement
Mankind Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,06,551.27 Crore | Market valuation of Mankind Pharma's shares. |
| Revenue (TTM) | 11,017.98 Crore | Total revenue generated by Mankind Pharma over the past twelve months. |
| Net Income (TTM) | +2,114.95 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 24.19% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 19.19% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +13.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +30.4% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 4.46 | Company's total debt divided by total shareholder equity. |
| Total Debt | 482.04 Crore | Sum of Mankind Pharma's current & long-term financial obligations. |
| Total Cash | 4,726.74 Crore | Total amount of liquid funds available to Mankind Pharma. |
Is Mankind Pharma A Good Buy For Long Term?
No valid response content found
To predict the Mankind Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Mankind Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Mankind Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Mankind Pharma shares in 2024, see the table below.
Advertisement
Mankind Pharma Share Price Target Table For 2024
| Mankind Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 2682.89 (+3.28%) | Price Action: 18 Oct 2024 High |
| 2024 Target 2 | 2654.00 (+2.16%) | Price Action: 30 Oct 2024 High |
| 2024 Target 1 | 2626.00 (+1.09%) | Price Action: 21 Oct 2024 Low |
| Current Price | 2597.64 | Mankind Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 2583.94 (-0.53%) | Price Action: 23 Oct 2024 High |
| Stop Loss 2 | 2550.00 (-1.84%) | Price Action: 22 Oct 2024 Low |
| Stop Loss 3 | 2513.00 (-3.26%) | Price Action: 23 Oct 2024 Low |
Summary: Mankind Pharma Share Price Prediction For 2024
In summary, Mankind Pharma has surged by ₹615.14, achieving a notable +31.03% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Mankind Pharma for 2024 predicts an additional rise of 1.09% to 3.28% by the end of 2024 with three potential targets T1: 2626.00, T2: 2654.00, T3: 2682.89. Stop Loss at SL1: 2583.94, SL2: 2550.00, SL3: 2513.00.
Mankind Pharma has a 52-week high of ₹2874.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1821.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Mankind Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Mankind Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Mankind Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Mankind Pharma shares in 2025, see the table below.
Advertisement
Mankind Pharma Share Price Target Table For 2025
| Mankind Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 3351.76 (+29.03%) | Price Action: Chart |
| 2025 Target 2 | 3289.26 (+26.62%) | Price Action: Chart |
| 2025 Target 1 | 3256.69 (+25.37%) | Fibonacci Extension Level 150% |
| Current Price | 2597.64 | Mankind Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 2420.00 (-6.84%) | Price Action: Apr 2024 High |
| Stop Loss 2 | 2393.50 (-7.86%) | Price Action: Aug 2024 Low |
| Stop Loss 3 | 2366.35 (-8.91%) | Price Action: Mar 2024 High |
Summary: Mankind Pharma Share Price Prediction For 2025
In summary, Mankind Pharma has surged by ₹615.14, achieving a notable +31.03% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Mankind Pharma for 2025 predicts an additional rise of 25.37% to 29.03% by the end of 2025 with three potential targets T1: 3256.69, T2: 3289.26, T3: 3351.76. Stop Loss at SL1: 2420.00, SL2: 2393.50, SL3: 2366.35.
Mankind Pharma has a All-Time high of ₹2870.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1821.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Mankind Pharma, we have created a specific page for that check here: Mankind Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Mankind Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Mankind Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 12.71% over the next 15 years.
For complete year by year Mankind Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Mankind Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Mankind Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹2,597.64 | [Current Price] |
| 2024 | ₹2,677.33 | 3.06% |
| 2025 | ₹3,553.55 | 32.72% |
| 2026 | ₹4,308.39 | 21.24% |
| 2027 | ₹5,171.34 | 20.02% |
| 2028 | ₹5,880.79 | 13.71% |
| 2029 | ₹6,547.34 | 11.33% |
| 2030 | ₹7,538.18 | 15.13% |
| 2031 | ₹8,254.5 | 9.5% |
| 2032 | ₹9,174.5 | 11.14% |
| 2033 | ₹9,822.82 | 7.06% |
| 2034 | ₹10,417.35 | 6.05% |
| 2035 | ₹11,522.81 | 10.61% |
| 2036 | ₹12,200.59 | 5.88% |
| 2037 | ₹13,177.66 | 8% |
| 2038 | ₹13,764.86 | 4.45% |
| 2039 | ₹14,289.07 | 3.8% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Mankind Pharma Past Performance
- In 2023, Mankind Pharma opening price was ₹1,300
- As of Thu 14 Nov 2024 the price stands at ₹2,597.64.
- This represents a Compound Annual Growth Rate (CAGR) of 41.36%.
- In 1 year, an investment of 10,000 would have become ₹19,981.84.
As we wrap up, we hope you like our study on Mankind Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
